克劳丁18抑制和非抑制胃腺癌的分子变化,以指导向治疗
1Algoma District Cancer Program, Sault Area Hospital, Sault Ste Marie, Ontario, Canada.
Tissue barriers
|May 7, 2024
概括
抑制克劳丁18表达的胃癌表现出明显的分子特征,包括WNT和PI3K通路的突变. 这些发现可能会为一小部分患者提供有针对性的治疗开发信息.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 分子生物学分子生物学
背景情况:
- 胃腺癌是一种具有高死亡率的侵袭性癌症.
- 目前针对晚期疾病的治疗主要依赖于非向化疗.
- 向疗法具有前景,但需要对分子驱动因素有更深入的了解.
研究的目的:
- 为了分析胃癌的临床和基因组景观,抑制了Claudin 18表达.
- 为了将这些特征与非抑制的Claudin 18的胃癌进行比较.
- 为了确定克劳丁18抑制的胃癌中的潜在治疗点.
主要方法:
- 癌症基因组图谱 (TCGA) 胃癌队列的分析.
- 胃癌与抑制克劳丁18mRNA表达 (z-score < -1) 与非抑制 (z-score > 0.5) 的比较.
- 评估临床特征,基因组突变和mRNA表达特征.
主要成果:
- 与克劳丁18抑制的胃癌占TCGA队列的7.7%.
- 两组之间没有观察到临床特征 (年龄,组织学,等级,阶段) 的显著差异.
- 抑制的Claudin 18癌症在TP53,WNT/β-catenin通路基因和FBXW7中显示出高的突变率,EMT和HLA基因表达变化.
结论:
- 克劳丁18抑制的胃癌子组在WNT和PI3K通路和不匹配修复 (MMR) 缺陷中表现出突变.
- 这些分子变化表明了替代向治疗的潜力.
- 这项研究可能会指导为胃癌患者开发新型治疗方法,而这些患者不符合Claudin 18向治疗的条件.
更多相关视频
10:28Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
11.1K
09:24Combined Conditional Knockdown and Adapted Sphere Formation Assay to Study a Stemness-Associated Gene of Patient-derived Gastric Cancer Stem Cells
Published on: May 9, 2020
4.4K
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Loss of Tumor Suppressor Gene Functions
4.8K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.8K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
